What are Peptides?
- Definition: Short chains of 2‑50 amino acids, the building blocks of proteins.
- Contrast with Proteins: Proteins have ≥50 amino acids and complex 3‑D folding; peptides are simpler and more flexible.
Biological Role of Endogenous Peptides
- Act as hormones, neurotransmitters, and local regulators.
- Regulate metabolism, immune response, tissue repair, appetite, and growth.
Peptide Therapy – Concept
- Utilises synthetic or naturally derived peptides to replicate the body’s signalling pathways.
- Lock‑and‑key binding to specific cell receptors → targeted response with fewer systemic side‑effects.
- Route of Administration: Primarily sub‑cutaneous injections (peptides are degraded in the GI tract).
Major Clinical Applications
- Diabetes & Obesity: GLP‑1 analogues (e.g., exenatide, semaglutide) improve glycaemic control and reduce appetite.
- Oncology: Peptide‑drug conjugates target tumour‑specific receptors, enhancing drug delivery precision.
- Infertility & Growth Disorders: Gonadotropin‑releasing hormone (GnRH) analogues, growth‑hormone‑releasing peptides.
- Regenerative Medicine: Peptides promoting muscle, nerve and tendon repair.
- Dermatology, Wound Healing, Osteoporosis, Cardiovascular diseases, Viral infections – emerging research areas.
Safety Concerns & Misuse
- Bio‑hacking Trend: Unapproved “research chemicals” sold online are self‑administered without clinical validation.
- Potential Risks: Endocrine imbalance, metabolic disturbances, cardiovascular events, allergic reactions.
- Regulatory Gap: Lack of stringent oversight for many peptide products marketed as supplements.
Policy & Regulatory Implications
- Need for stringent drug approval processes under the Drugs and Cosmetics Act, 1940.
- Pharmacovigilance mechanisms to monitor adverse events.
- Coordination between DCGI, CDSCO, and International regulatory bodies for cross‑border control of illicit peptide sales.
- Public awareness campaigns on the dangers of self‑injection and counterfeit products.
Constitutional/Legal Provisions (if applicable)
- Article 21 – Right to health; state’s duty to ensure safe medical products.
- National Health Policy 2017 – Emphasises regulation of emerging therapies.
Key Take‑aways for UPSC
- Understand peptide structure, therapeutic scope, and administration.
- Recognise the regulatory challenges and public health implications.
- Relate peptide therapy to broader themes of Science & Technology, Health, and Governance.